General Biotechnology, Insights

Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents

This paper was originally published by Qiaolei Jiang and Chunjuan Luan in Globalization and Health 2018 14:92 under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Abstract Background Despite the …

Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents Read Post »

General Biotechnology, Insights

Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges

This article was originally published by Basavaraj S, Guru V. Betageri in Acta Pharmaceutica Sinica B Volume 4, Issue 1, February 2014, Pages 3-17 under a Creative Commons License. Abstract Drug discovery and development…
The post Can formulation and d…

Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges Read Post »

General Biotechnology, Insights

Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?

This paper was originally published by T. Joseph Mattingly, Joseph F. Levy, Julia F. Slejko, Nneka C. Onwudiwe, and Eleanor M. Perfetto in PharmacoEconomics Volume 36, Issue 9 under a Creative Commons…
The post Estimating Drug Costs: How do Manufacture…

Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References? Read Post »

General Biotechnology, Insights

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks

This paper was originally published by Toon van der Gronde, Carin A. Uyl-de Groot, and Toine Pieters in PLoS ONE 12(8): e0182613 under a creative commons license. Abstract Context Recent public outcry…
The post Addressing the challenge of high-priced p…

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks Read Post »

Biotechblog
Scroll to Top